Zhayvoronok, N., Kolenko, O., Danilova, L., & Sorokin, E. The initial results of using brolucizumab (Beovu®), an angiogenesis inhibitor, for choroidal neovascularization in patients with age-related macular degeneration. Prime-Media.
Chicago Style (17th ed.) CitationZhayvoronok, N.S, O.V Kolenko, L.P Danilova, and E.L Sorokin. The Initial Results of Using Brolucizumab (Beovu®), an Angiogenesis Inhibitor, for Choroidal Neovascularization in Patients with Age-related Macular Degeneration. Prime-Media.
MLA (9th ed.) CitationZhayvoronok, N.S, et al. The Initial Results of Using Brolucizumab (Beovu®), an Angiogenesis Inhibitor, for Choroidal Neovascularization in Patients with Age-related Macular Degeneration. Prime-Media.
Warning: These citations may not always be 100% accurate.